R&D Trends

BMS and Duke form strategic relationship

Wednesday, February 29, 2012 02:31 PM

Bristol-Myers Squibb (BMS) and Duke Translational Medicine Institute (DTMI) have formed a strategic relationship to broaden interactions between the two organizations.

More... »

North Shore-LIJ Health System joins Cleveland Clinic’s Innovation Alliance

Tuesday, February 28, 2012 06:11 AM

North Shore-LIJ Health System, the second-largest nonprofit in the U.S. secular healthcare system, has joined Cleveland Clinic’s Innovation Alliance program to enhance the discovery, development, deployment and commercialization of new technologies.

More... »

Selventa and Janssen form research agreement

Monday, February 27, 2012 03:15 PM

Cambridge, Mass.-based Selventa, a personalized healthcare company focused on development of predictive biomarker panels, has formed a multi-year research agreement with Janssen R&D in immunological disease.

More... »

Paladin partners with Litha, aid merge of South African pharmas

Thursday, February 23, 2012 06:30 AM

Montreal-based Paladin Labs has formed a strategic partnership to accelerate its buyout of the remaining shares of South Africa-based Pharmaplan and merge the business with the pharma division of Litha Healthcare Group, based in South Africa.

More... »

Pfizer and Hisun to increase access to high-quality generics

Wednesday, February 22, 2012 02:00 PM

Pfizer and Zhejiang Hisun Pharmaceutical are establishing a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Global outGRID will centralize Alzheimer’s research online

Wednesday, February 22, 2012 01:56 PM

Europe’s neuGRID, a cloud-computing infrastructure that stores and analyses a vast database of 3D brain scans, is joining with Canada’s CBRAIN and the U.S.’s LONI to create outGRID, a global online system to centralize and boost Alzheimer’s research initiatives.

More... »

Enanta, Novartis collaborate to advance Hep C inhibitor

Wednesday, February 22, 2012 01:53 PM

Enanta Pharmaceuticals, a developer of best-in-class small molecule drugs in the infectious disease field, has formed an exclusive collaboration and license agreement with Novartis for the worldwide development, manufacture and commercialization of its lead development candidate, EDP-239, a hepatitis C virus inhibitor.

More... »

Faculty of 1000 to launch open access publishing venture

Friday, February 17, 2012 01:50 PM

Faculty of 1000 (F1000) is set to launch F1000 Research, a new fully open access publishing program across biology and medicine, later this year.

More... »

Complete Genomics to provide whole genome sequencing to Mayo Clinic

Friday, February 17, 2012 01:44 PM

Complete Genomics has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.

More... »

Evotec, IR Pharma partner for respiratory disease drug discovery

Friday, February 17, 2012 01:41 PM

Evotec and IR Pharma have formed an exclusive strategic alliance to provide integrated drug discovery solutions to pharmaceutical and biotech companies in the field of respiratory diseases.

More... »